Lee Ainslie's TMO Position Overview
Lee Ainslie (via Maverick Capital LTD) currently holds 297,568 shares of Thermo Fisher Scientific Inc. (TMO) worth $200.87 M, representing 1.57% of the portfolio. First purchased in 2018-Q3, this medium-term investment has been held for 17 quarters.
Based on 13F filings, Lee Ainslie has maintained a strategic position in TMO, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2026, adding 297,568 shares. Largest reduction occurred in Q2 2019, reducing 26,370 shares.
Analysis based on 13F filings available since 2013 Q2
Lee Ainslie's Thermo Fisher Scientific (TMO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Thermo Fisher Scientific (TMO) Trades by Lee Ainslie
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | +297,568 | New Buy | 297,568 | $675.05 |
| Q2 2024 | -749 | Sold Out | 0 | $0.00 |
| Q1 2024 | -772 | Reduce 50.76% | 749 | $581.21 |
| Q4 2023 | +738 | Add 94.25% | 1,521 | $530.79 |
| Q3 2023 | +783 | New Buy | 783 | $506.17 |
| Q3 2021 | -876 | Sold Out | 0 | $0.00 |
| Q2 2021 | -1,519 | Reduce 63.42% | 876 | $504.57 |
| Q1 2021 | +1,297 | Add 118.12% | 2,395 | $456.37 |
| Q4 2020 | +1,098 | New Buy | 1,098 | $465.39 |
| Q2 2020 | -221 | Sold Out | 0 | $0.00 |
| Q1 2020 | +221 | New Buy | 221 | $285.07 |
| Q4 2019 | -12,086 | Sold Out | 0 | $0.00 |
| Q3 2019 | +12,086 | New Buy | 12,086 | $291.25 |
| Q2 2019 | -26,370 | Sold Out | 0 | $0.00 |
| Q1 2019 | +4,350 | Add 19.75% | 26,370 | $273.72 |
| Q4 2018 | +10,690 | Add 94.35% | 22,020 | $223.80 |
| Q3 2018 | +11,330 | New Buy | 11,330 | $244.04 |
Lee Ainslie's Thermo Fisher Scientific Investment FAQs
Lee Ainslie first purchased Thermo Fisher Scientific Inc. (TMO) in Q3 2018, acquiring 11,330 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Lee Ainslie has held Thermo Fisher Scientific Inc. (TMO) for 17 quarters since Q3 2018.
Lee Ainslie's largest addition to Thermo Fisher Scientific Inc. (TMO) was in Q3 2026, adding 297,568 shares worth $200.87 M.
According to the latest 13F filing for Q3 2026, Lee Ainslie's firm, Maverick Capital LTD, owns 297,568 shares of Thermo Fisher Scientific Inc. (TMO), valued at approximately $200.87 M.
As of the Q3 2026 filing, Thermo Fisher Scientific Inc. (TMO) represents approximately 1.57% of Lee Ainslie's publicly disclosed stock portfolio, making it one of their key holdings.
Lee Ainslie's peak holding in Thermo Fisher Scientific Inc. (TMO) was 297,568 shares, as reported at the end of Q3 2026.